Science Explorer Back to mapMap
Discussion
Researcher · Universitat Pompeu Fabra · Spain

Miguel López‐Botet

Miguel López‐Botet publishes mostly in Immunology, Epidemiology and Oncology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Cytomegalovirus and herpesvirus research.

ORCID 0000-0003-4882-065X OpenAlex
World rank
#216,157
of 7,710,434 ranked researchers
Rank in Spain
#3,315
of 204,306
Works
244
Citations
17k
Citations per work
70.8
h-index
68
i10-index 167Top 1.7% in Immunology
Miguel López‐Botet

What does Miguel López‐Botet research?

Miguel López‐Botet's work is mostly in Immunology and Microbiology (59%), Medicine (22%), Biochemistry, Genetics and Molecular Biology (3%).

Life Sciences: 152 works · 62.5% of their workImmunology and Microbiology: 144 works · 59.2% of their workImmunology: 144 works · 59.2% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 3.3% of their workMolecular Biology: 8 works · 3.3% of their workHealth Sciences: 54 works · 22.2% of their workMedicine: 54 works · 22.2% of their workEpidemiology: 24 works · 9.7% of their workOncology: 17 works · 7.1% of their workRadiology, Nuclear Medicine and Imaging: 7 works · 3.0% of their workHematology: 6 works · 2.4% of their workEverything else: 37 works · 15.3% of their workTHEIR WORKMiguelLópez‐Botet244works
Life Sciences62%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology14459.2%
    2. Biochemistry, Genetics and Molecular Biology83.3%
    1. Medicine5422.2%
  3. Everything else3715.3%
  1. 1Immunology59% of their works
  2. 2Epidemiology10% of their works
  3. 3Oncology7% of their works
  4. 4Molecular Biology3% of their works
  5. 5Radiology, Nuclear Medicine and Imaging3% of their works
  6. 6Hematology2% of their works

Research topics

Which keywords describe Miguel López‐Botet's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß, Cytomegalovirus, Infection, Cancer Immunotherapy and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. NK Cell Recognition1671 topic
  2. Natural Killer Cells1671 topic
  3. Foxp31241 topic
  4. TGF-ß1241 topic
  5. Cytomegalovirus461 topic
  6. Infection461 topic
  7. Cancer Immunotherapy402 topics
  8. Dendritic Cells231 topic
  9. Immunity231 topic
  10. CAR T Cells171 topic
  11. Chimeric Antigen Receptor171 topic
  12. Fc Receptors171 topic
  13. Therapeutic Antibodies171 topic
  14. Decidual NK Cells161 topic
  15. Regulatory T Cells161 topic
  16. Cell Adhesion101 topic
  17. Integrins101 topic

Where does Miguel López‐Botet work?

Miguel López‐Botet's main affiliation in the publication record is Universitat Pompeu Fabra, Spain.

How many publications and citations does Miguel López‐Botet have?

OpenAlex counts 244 works and 17,269 citations for Miguel López‐Botet, an h-index of 68, ranking #216,157 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Miguel López‐Botet. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.